Merit Medical Systems, Inc. (MMSI)
USD 88.48
(-4.36%)
USD 88.48
(-4.36%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 94.41 Million USD | 26.7% |
| 2022 | 74.51 Million USD | 53.79% |
| 2021 | 48.45 Million USD | 592.27% |
| 2020 | -9.84 Million USD | -280.57% |
| 2019 | 5.45 Million USD | -87.03% |
| 2018 | 42.01 Million USD | 52.66% |
| 2017 | 27.52 Million USD | 36.79% |
| 2016 | 20.12 Million USD | -15.47% |
| 2015 | 23.8 Million USD | 3.6% |
| 2014 | 22.97 Million USD | 38.65% |
| 2013 | 16.57 Million USD | -15.93% |
| 2012 | 19.71 Million USD | -14.47% |
| 2011 | 23.04 Million USD | 84.94% |
| 2010 | 12.46 Million USD | -44.7% |
| 2009 | 22.53 Million USD | 8.7% |
| 2008 | 20.72 Million USD | 32.97% |
| 2007 | 15.58 Million USD | 26.72% |
| 2006 | 12.3 Million USD | -22.04% |
| 2005 | 15.77 Million USD | -12.01% |
| 2004 | 17.93 Million USD | 3.68% |
| 2003 | 17.29 Million USD | 52.92% |
| 2002 | 11.31 Million USD | 67.9% |
| 2001 | 6.73 Million USD | 714.94% |
| 2000 | 826.55 Thousand USD | -74.17% |
| 1999 | 3.2 Million USD | 28.0% |
| 1998 | 2.5 Million USD | 212.5% |
| 1997 | 800 Thousand USD | -63.64% |
| 1996 | 2.2 Million USD | 83.33% |
| 1995 | 1.2 Million USD | -7.69% |
| 1994 | 1.3 Million USD | -27.78% |
| 1993 | 1.8 Million USD | 50.0% |
| 1992 | 1.2 Million USD | -7.69% |
| 1991 | 1.3 Million USD | 1200.0% |
| 1990 | 100 Thousand USD | 125.0% |
| 1989 | -400 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 28.44 Million USD | -20.38% |
| 2024 Q2 | 35.72 Million USD | 26.51% |
| 2024 Q1 | 28.24 Million USD | 2.21% |
| 2023 Q2 | 20.24 Million USD | -2.21% |
| 2023 Q3 | 25.83 Million USD | 27.61% |
| 2023 Q4 | 27.62 Million USD | 6.95% |
| 2023 FY | 94.41 Million USD | 26.7% |
| 2023 Q1 | 20.7 Million USD | -38.02% |
| 2022 Q4 | 33.4 Million USD | 118.71% |
| 2022 Q3 | 15.27 Million USD | -0.17% |
| 2022 Q2 | 15.29 Million USD | 45.07% |
| 2022 FY | 74.51 Million USD | 53.79% |
| 2022 Q1 | 10.54 Million USD | -48.84% |
| 2021 Q2 | 4.91 Million USD | -55.14% |
| 2021 Q3 | 11.96 Million USD | 143.43% |
| 2021 Q4 | 20.61 Million USD | 72.25% |
| 2021 FY | 48.45 Million USD | 592.27% |
| 2021 Q1 | 10.95 Million USD | -28.74% |
| 2020 Q1 | -3.15 Million USD | 24.99% |
| 2020 Q3 | -3 Million USD | 84.21% |
| 2020 Q4 | 15.37 Million USD | 611.07% |
| 2020 FY | -9.84 Million USD | -280.57% |
| 2020 Q2 | -19.05 Million USD | -504.25% |
| 2019 Q2 | 6.85 Million USD | 10.72% |
| 2019 Q3 | -3.39 Million USD | -149.54% |
| 2019 Q4 | -4.2 Million USD | -23.75% |
| 2019 FY | 5.45 Million USD | -87.03% |
| 2019 Q1 | 6.19 Million USD | -32.58% |
| 2018 FY | 42.01 Million USD | 52.66% |
| 2018 Q2 | 10.94 Million USD | 107.65% |
| 2018 Q4 | 9.18 Million USD | -44.71% |
| 2018 Q1 | 5.26 Million USD | -22.58% |
| 2018 Q3 | 16.61 Million USD | 51.9% |
| 2017 Q3 | -3.56 Million USD | -137.64% |
| 2017 FY | 27.52 Million USD | 36.79% |
| 2017 Q4 | 6.8 Million USD | 290.7% |
| 2017 Q2 | 9.48 Million USD | -35.94% |
| 2017 Q1 | 14.8 Million USD | 97.22% |
| 2016 Q4 | 7.5 Million USD | 671.43% |
| 2016 Q1 | 4.35 Million USD | -32.11% |
| 2016 Q2 | 7.29 Million USD | 67.55% |
| 2016 Q3 | 973 Thousand USD | -86.65% |
| 2016 FY | 20.12 Million USD | -15.47% |
| 2015 FY | 23.8 Million USD | 3.6% |
| 2015 Q2 | 7.4 Million USD | 43.04% |
| 2015 Q4 | 6.4 Million USD | 33.02% |
| 2015 Q1 | 5.17 Million USD | -40.33% |
| 2015 Q3 | 4.81 Million USD | -34.9% |
| 2014 Q4 | 8.67 Million USD | 11.68% |
| 2014 Q3 | 7.76 Million USD | 108.93% |
| 2014 Q2 | 3.71 Million USD | 31.63% |
| 2014 FY | 22.97 Million USD | 38.65% |
| 2014 Q1 | 2.82 Million USD | -56.83% |
| 2013 Q2 | 3.75 Million USD | 459.17% |
| 2013 FY | 16.57 Million USD | -15.93% |
| 2013 Q4 | 6.54 Million USD | 16.64% |
| 2013 Q1 | 671 Thousand USD | 4.68% |
| 2013 Q3 | 5.6 Million USD | 49.44% |
| 2012 Q3 | 7.22 Million USD | 18.56% |
| 2012 Q4 | 641 Thousand USD | -91.13% |
| 2012 Q2 | 6.09 Million USD | 6.04% |
| 2012 Q1 | 5.74 Million USD | 15.65% |
| 2012 FY | 19.71 Million USD | -14.47% |
| 2011 Q1 | 6.63 Million USD | 57.7% |
| 2011 Q3 | 4.56 Million USD | -33.6% |
| 2011 FY | 23.04 Million USD | 84.94% |
| 2011 Q2 | 6.87 Million USD | 3.51% |
| 2011 Q4 | 4.97 Million USD | 8.92% |
| 2010 FY | 12.46 Million USD | -44.7% |
| 2010 Q2 | 5.71 Million USD | 26.77% |
| 2010 Q3 | -1.97 Million USD | -134.52% |
| 2010 Q4 | 4.21 Million USD | 313.38% |
| 2010 Q1 | 4.5 Million USD | -11.03% |
| 2009 Q4 | 5.06 Million USD | -16.73% |
| 2009 FY | 22.53 Million USD | 8.7% |
| 2009 Q1 | 5.53 Million USD | 2.69% |
| 2009 Q2 | 5.84 Million USD | 5.49% |
| 2009 Q3 | 6.08 Million USD | 4.18% |
| 2008 Q2 | 5.81 Million USD | 34.77% |
| 2008 Q3 | 5.2 Million USD | -10.62% |
| 2008 Q4 | 5.39 Million USD | 3.69% |
| 2008 FY | 20.72 Million USD | 32.97% |
| 2008 Q1 | 4.31 Million USD | -8.69% |
| 2007 Q2 | 3.59 Million USD | 21.12% |
| 2007 Q4 | 4.72 Million USD | 10.08% |
| 2007 FY | 15.58 Million USD | 26.72% |
| 2007 Q1 | 2.96 Million USD | -2.75% |
| 2007 Q3 | 4.29 Million USD | 19.44% |
| 2006 Q1 | 2.4 Million USD | -35.02% |
| 2006 Q2 | 3.52 Million USD | 46.69% |
| 2006 Q3 | 3.32 Million USD | -5.59% |
| 2006 Q4 | 3.05 Million USD | -8.18% |
| 2006 FY | 12.3 Million USD | -22.04% |
| 2005 Q4 | 3.69 Million USD | 11.06% |
| 2005 Q3 | 3.32 Million USD | -28.93% |
| 2005 Q2 | 4.68 Million USD | 14.9% |
| 2005 Q1 | 4.07 Million USD | -5.19% |
| 2005 FY | 15.77 Million USD | -12.01% |
| 2004 Q2 | 5.07 Million USD | 15.9% |
| 2004 Q3 | 4.18 Million USD | -17.4% |
| 2004 Q4 | 4.29 Million USD | 2.58% |
| 2004 FY | 17.93 Million USD | 3.68% |
| 2004 Q1 | 4.37 Million USD | -6.62% |
| 2003 Q1 | 3.75 Million USD | 18.89% |
| 2003 FY | 17.29 Million USD | 52.92% |
| 2003 Q2 | 4.2 Million USD | 12.08% |
| 2003 Q4 | 4.68 Million USD | 0.73% |
| 2003 Q3 | 4.65 Million USD | 10.61% |
| 2002 Q4 | 3.15 Million USD | 0.98% |
| 2002 Q1 | 2.32 Million USD | 19.59% |
| 2002 Q2 | 2.7 Million USD | 16.11% |
| 2002 Q3 | 3.12 Million USD | 15.68% |
| 2002 FY | 11.31 Million USD | 67.9% |
| 2001 Q3 | 1.74 Million USD | -6.12% |
| 2001 Q4 | 1.94 Million USD | 11.51% |
| 2001 Q2 | 1.85 Million USD | 56.67% |
| 2001 FY | 6.73 Million USD | 714.94% |
| 2001 Q1 | 1.18 Million USD | 117.01% |
| 2000 Q3 | 394.39 Thousand USD | 777.86% |
| 2000 Q1 | -159.48 Thousand USD | -115.95% |
| 2000 Q2 | 44.92 Thousand USD | 128.17% |
| 2000 Q4 | 546.71 Thousand USD | 38.62% |
| 2000 FY | 826.55 Thousand USD | -74.17% |
| 1999 Q3 | 900 Thousand USD | 12.5% |
| 1999 Q1 | 600 Thousand USD | -25.0% |
| 1999 Q4 | 1 Million USD | 11.11% |
| 1999 Q2 | 800 Thousand USD | 33.33% |
| 1999 FY | 3.2 Million USD | 28.0% |
| 1998 Q3 | 700 Thousand USD | 16.67% |
| 1998 Q2 | 600 Thousand USD | 50.0% |
| 1998 Q1 | 400 Thousand USD | 100.0% |
| 1998 Q4 | 800 Thousand USD | 14.29% |
| 1998 FY | 2.5 Million USD | 212.5% |
| 1997 FY | 800 Thousand USD | -63.64% |
| 1997 Q1 | 200 Thousand USD | -60.0% |
| 1997 Q4 | 200 Thousand USD | 100.0% |
| 1997 Q3 | 100 Thousand USD | -66.67% |
| 1997 Q2 | 300 Thousand USD | 50.0% |
| 1996 Q2 | 500 Thousand USD | 0.0% |
| 1996 FY | 2.2 Million USD | 83.33% |
| 1996 Q3 | 700 Thousand USD | 40.0% |
| 1996 Q4 | 500 Thousand USD | -28.57% |
| 1996 Q1 | 500 Thousand USD | 25.0% |
| 1995 FY | 1.2 Million USD | -7.69% |
| 1995 Q4 | 400 Thousand USD | -20.0% |
| 1995 Q3 | 500 Thousand USD | 150.0% |
| 1995 Q2 | 200 Thousand USD | 100.0% |
| 1995 Q1 | 100 Thousand USD | 150.0% |
| 1994 Q4 | -200 Thousand USD | -166.67% |
| 1994 FY | 1.3 Million USD | -27.78% |
| 1994 Q1 | 600 Thousand USD | 20.0% |
| 1994 Q2 | 600 Thousand USD | 0.0% |
| 1994 Q3 | 300 Thousand USD | -50.0% |
| 1993 Q2 | 400 Thousand USD | -20.0% |
| 1993 FY | 1.8 Million USD | 50.0% |
| 1993 Q1 | 500 Thousand USD | 0.0% |
| 1993 Q4 | 500 Thousand USD | 25.0% |
| 1993 Q3 | 400 Thousand USD | 0.0% |
| 1992 Q2 | 400 Thousand USD | 300.0% |
| 1992 Q1 | 100 Thousand USD | -66.67% |
| 1992 Q3 | 300 Thousand USD | -25.0% |
| 1992 FY | 1.2 Million USD | -7.69% |
| 1992 Q4 | 500 Thousand USD | 66.67% |
| 1991 FY | 1.3 Million USD | 1200.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q3 | 300 Thousand USD | 0.0% |
| 1991 Q4 | 300 Thousand USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 FY | 100 Thousand USD | 125.0% |
| 1990 Q2 | - USD | 0.0% |
| 1989 FY | -400 Thousand USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 249.094% |
| AngioDynamics, Inc. | -184.34 Million USD | 151.213% |
| AtriCure, Inc. | -30.43 Million USD | 410.175% |
| Avinger, Inc. | -18.32 Million USD | 615.344% |
| Azenta, Inc. | -14.25 Million USD | 762.208% |
| BioLife Solutions, Inc. | -66.42 Million USD | 242.127% |
| The Cooper Companies, Inc. | 294.2 Million USD | 67.909% |
| Daxor Corporation | 280.64 Thousand USD | -33541.32% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 721.207% |
| Femasys Inc. | -14.24 Million USD | 762.667% |
| GlucoTrack, Inc. | -7.09 Million USD | 1430.294% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 2864.597% |
| Hologic, Inc. | 789.5 Million USD | 88.042% |
| ICU Medical, Inc. | -29.65 Million USD | 418.365% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 94.749% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 787.072% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | -213.606% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 1516.853% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 1516.853% |
| Masimo Corporation | 81.5 Million USD | -15.842% |
| Microbot Medical Inc. | -10.74 Million USD | 979.06% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | -712.109% |
| Nephros, Inc. | -1.57 Million USD | 6094.349% |
| NovoCure Limited | -207.04 Million USD | 145.6% |
| NEXGEL, Inc. | -3.15 Million USD | 3090.529% |
| NEXGEL, Inc. | -3.15 Million USD | 3090.529% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 199.569% |
| OraSure Technologies, Inc. | 53.65 Million USD | -75.959% |
| Pro-Dex, Inc. | 2.12 Million USD | -4338.693% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 323.67% |
| Predictive Oncology Inc. | -13.98 Million USD | 775.137% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | 3298.88% |
| QuidelOrtho Corporation | -10.1 Million USD | 1034.762% |
| Repligen Corporation | 41.57 Million USD | -127.075% |
| Sanara MedTech Inc. | -4.3 Million USD | 2293.973% |
| STAAR Surgical Company | 21.34 Million USD | -342.268% |
| Sharps Technology, Inc. | -9.84 Million USD | 1059.302% |
| Utah Medical Products, Inc. | 16.63 Million USD | -467.544% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 171.523% |
| Jin Medical International Ltd. | 2.87 Million USD | -3180.176% |